Press Releases

News

Roswell Park Workforce Swells to Record Level With Latest Slate of Hires and Promotions

The team at Roswell Park Comprehensive Cancer Center has reached record levels, growing to a workforce of more than 3,500. The latest appointments announced by Roswell Park President and CEO Candace S. Johnson, PhD, and her senior leadership team mark a milestone for the 121-year-old cancer center, reflecting expansion across all areas of operations, from clinical care and education to new frontiers in cancer research.

News

Roswell Park Presentations at TCT 2019 Focus on Tools for Predicting Patient Outcomes

Particularly in the realm of cancer care, which can mean years of treatment and follow-up for patients, clinicians look to a number of tools and metrics to guide their decision-making regarding what, if any, treatment options and care approaches may be most effective for a particular patient. Roswell Park Comprehensive Cancer Center experts were invited to highlight ways to optimize these predictive strategies to improve both treatment and rehabilitation of patients undergoing hematopoietic stem cell transplantation, also known as bone marrow transplant, during the TCT/Transplantation and Cellular Therapy Meetings now underway in Houston, Texas.
News

Roswell Park Researchers Identify Protein That Contributes to Racial Disparities in Prostate Cancer

Cancer researchers have long known that prostate cancer tends to be more common, more aggressive and more resistant to existing treatments in African-Americans than in Caucasian-Americans, but they’re only beginning to understand why. A Roswell Park Comprehensive Cancer Center study published today points to cellular factors that appear to be driving these disparities — mitochondrial differences that prevent formation of the cancer-killing “death wheel” apoptosome protein complex — and proposes a strategy for overcoming these factors with new therapeutic targets.
News

Roswell Park Reports New Path to Overcoming Drug Resistance in HER2-Positive Breast Cancer

The HER2 protein, which encourages the growth of cancer cells, is present in about 20% of all breast cancers. While HER2-positive breast cancers tend to be very aggressive, today the prognosis is generally very good, thanks to the introduction of HER2 inhibitors such as trastuzumab (brand name Herceptin). However, not all HER2-positive breast cancers respond to existing HER2 inhibitors.
News

Roswell Park, NFMMC Launch Cancer Care Collaboration

Roswell Park Comprehensive Cancer Center and Niagara Falls Memorial Medical Center today announced a collaborative effort to greatly improve the availability of cancer care in Niagara County. The first step of the new collaborative partnership is a comprehensive thoracic clinical program.
News

Genetic and Metabolic Differences May Help Explain Inconsistencies in Studies on Diet and Cancer

While research suggests that increasing dietary intake of lignans — nutrients found in whole grains, vegetables, fruits and seeds — may reduce risk of breast cancer, the findings from studies testing this hypothesis have been inconsistent. A new study from Roswell Park Comprehensive Cancer Center, published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association of Cancer Research (AACR), examines how women of different backgrounds metabolize lignans. What these scientists learned may help explain why associations between diet and breast cancer risk have been difficult to demonstrate consistently.
News

Roswell Park Releases Super Bowl Ad Early

We just couldn’t wait any longer. For the fourth time, Roswell Park Comprehensive Cancer Center has launched a 30-second regional television commercial, set to air in the Buffalo region during the Super Bowl on Sunday, February 3. The spot is called “Dear Cancer…”
Drs. Erik Knudsen and Agnieszka Witkiewicz
News

Roswell Park Researchers Propose Two New Strategies for Treating Pancreatic Cancer

In a pair of new studies, researchers from Roswell Park Comprehensive Cancer Center outline strategies for overcoming pancreatic cancer’s resistance to treatment through approaches that exploit this cancer’s reliance on uncontrolled, or deregulated, cell proliferation. The companion articles in Oncogene, which is published by the Nature Publishing Group, and Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR), report promising findings from preclinical studies employing existing treatments that have been effective against other solid-tumor cancers.
News

Roswell Park Becomes Region’s Only NPF Center for Pancreatic Cancer

The National Pancreas Foundation (NPF) has designated Roswell Park Comprehensive Cancer Center as an NPF Center for pancreatic cancer. The Buffalo-based cancer center is one of only 42 centers nationwide — and the only one in Western New York — to be named to this network of premier healthcare facilities recognized for their focus on multidisciplinary treatment of pancreas disease and for their commitment to treating “the whole patient,” with a focus on the best possible outcomes and an improved quality of life.